Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL864P (RNA, 7SL, cytoplasmic 864, pseudogene) is classified as a pseudogene, specifically a non-coding RNA pseudogene[1][4]. It is related to 7SL RNA, a component of the signal recognition particle (SRP) ribonucleoprotein complex integral to protein targeting in cells[3][5]. However, as a pseudogene, RN7SL864P is a nonfunctional segment of DNA homologous to 7SL RNA genes, generally unable to produce a functional RNA or protein product[4][1]. Pseudogenes like RN7SL864P arise typically by duplication, retrotransposition, or mutation of active RNA genes and are considered nonfunctional "gene fossils" within the genome[4][6]. Hence, RN7SL864P is not a therapeutic target, does not belong to typical target classes such as receptors or enzymes, and currently has no recognized biological functions, disease roles, drug interactions, biomarker value, or safety concerns[1][4]. If you are seeking structured information on true SRP RNA or 7SL RNA (the functional parent molecule), that would have different properties and functions[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 864, pseudogene (RN7SL864P).